Karen Rqap-Gcp
at Arbutus Biopharma Corporation
Karen Rqap-Gcp's Professional Contact Details
Email (Verified)
****@arbutusbio.com
HQ
(604) 419-3200
Location
Vancouver, British Columbia, Canada
Company
Arbutus Biopharma Corporation
Karen Rqap-Gcp's Current Company Details
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis...
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. In addition to our HBV Assets, we are developing a pipeline of programs that leverage our expertise in RNA interference (RNAi) therapeutics and our Lipid Nanoparticle (LNP) technology.
Public Symbol
ABUS
Founded Year
1992
Organization Website
arbutusbio.com
Organization Languages
English
Organization Revenue
15000
Current Technologies
outlook
office 365
asp net
akamai rum
google analytics
omniture adobe
nginx
mobile friendly
google font api
youtube
new relic
addthis
biotechnology
pharmaceutical
biopharma
genetics
medical
Karen Rqap-Gcp's Work History and Education
Arbutus Biopharma Corporation
Present
Colleagues at Arbutus Biopharma Corporation
Senior Fellow - Center for High Impact Philanthropy and Wharton Social Impact
Prospect on LinkedIn
Find emails on Linkedln, Sales Navigator, AngelList, CrunchBase, Google etc.
Download
Extension
